← FDA Drug Approvals (Drugs@FDA)

NAMZARIC

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2014-12-23

Drug application

FDA Application #

NDA206439

Application type

New Drug Application

Brand name

NAMZARIC

Generic name

MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE

Active ingredients

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2014-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown